ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,669.04
-0.08%
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs Yen
157.2625
0.00%
Brent Oil
81.295
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NYSE
  6. Johnson and Johnson (JNJ)

  7. Johnson and Johnson (JNJ) ニュース

JNJ

Johnson and Johnson (JNJ)

Johnson and Johnson
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:JNJ
日付受信時刻ニュースソース見出しコード企業名
2024/05/3121 : 45Business WireJohnson & Johnson Completes Acquisition of Shockwave MedicalNYSE:JNJJohnson and Johnson
2024/05/3006 : 48PR Newswire (US)Sarepta Therapeutics Set to Join S&P MidCap 400NYSE:JNJJohnson and Johnson
2024/05/2905 : 10Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:JNJJohnson and Johnson
2024/05/2820 : 35GlobeNewswire Inc.Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic DermatitisNYSE:JNJJohnson and Johnson
2024/05/2820 : 30Business WireJohnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic DermatitisNYSE:JNJJohnson and Johnson
2024/05/2301 : 05Business WireProposed Class Action Filed by Six Law Firms Alleging Series of Fraudulent Transfers by Johnson & Johnson in Talc LitigationNYSE:JNJJohnson and Johnson
2024/05/2123 : 43Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNYSE:JNJJohnson and Johnson
2024/05/2106 : 17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:JNJJohnson and Johnson
2024/05/2105 : 34Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NYSE:JNJJohnson and Johnson
2024/05/2105 : 01Edgar (US Regulatory)Form 8-K - Current reportNYSE:JNJJohnson and Johnson
2024/05/2022 : 31Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNYSE:JNJJohnson and Johnson
2024/05/1800 : 21Edgar (US Regulatory)Form 8-K - Current reportNYSE:JNJJohnson and Johnson
2024/05/1720 : 36IH Market NewsOpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More NewsNYSE:JNJJohnson and Johnson
2024/05/1705 : 16Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JNJJohnson and Johnson
2024/05/1620 : 30Business WireJohnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis TreatmentNYSE:JNJJohnson and Johnson
2024/05/1506 : 01Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:JNJJohnson and Johnson
2024/05/1420 : 26IH Market NewsWalmart Corporate Job Cuts and Office Centralization, GameStop and AMC Surge, and More NewsNYSE:JNJJohnson and Johnson
2024/05/1419 : 05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:JNJJohnson and Johnson
2024/05/1321 : 36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:JNJJohnson and Johnson
2024/05/1106 : 14Edgar (US Regulatory)Form 13F-HR - Quarterly report filed by institutional managers, HoldingsNYSE:JNJJohnson and Johnson
2024/05/0905 : 30Business WireJohnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNYSE:JNJJohnson and Johnson
2024/05/0705 : 05GlobeNewswire Inc.Shockwave Medical Reports First Quarter 2024 Financial ResultsNYSE:JNJJohnson and Johnson
2024/05/0119 : 30Business WireJohnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” ReorganizationNYSE:JNJJohnson and Johnson
2024/04/2305 : 30Business WireJohnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)NYSE:JNJJohnson and Johnson
2024/04/1920 : 31IH Market NewsParamount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and MoreNYSE:JNJJohnson and Johnson
2024/04/1719 : 59IH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:JNJJohnson and Johnson
2024/04/1705 : 33IH Market NewsU.S. Stocks Finish Lackluster Session Narrowly MixedNYSE:JNJJohnson and Johnson
2024/04/1623 : 46Business WireCORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
2024/04/1622 : 52IH Market NewsJ&J’s Q1 2024 sales rise 2.3% to $21.4 billionNYSE:JNJJohnson and Johnson
2024/04/1622 : 09IH Market NewsDow Looks To Snap Six-Day Losing Streak As UnitedHealth SurgesNYSE:JNJJohnson and Johnson
 Showing the most relevant articles for your search:NYSE:JNJ

最近閲覧した銘柄

LSE
91ET
Wells Fargo 35
BIT
G
Generali
BIT
P13DB8
BNP Paribas Issuance
BIT
O8JP89
Morgan Stanley BV
BIT
TLS
Telesia
BIT
P17RQ7
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有